Showing results (171-180 of 260) with videos related to
Sort By:
Pageof 26
Oncotarget|May 1, 2017
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27Alessandra Dondero, Beatrice Casu, Francesca Bellora, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 14, 2016
Clinical relevance of the HCV protease inhibitor-resistant mutant viral load assessed by ultra-deep pyrosequencing in treatment failureSofiane Mohamed, Marc Bourliere, Souad Benali, et al.Leukemia & Lymphoma|February 11, 2014
Efficacy and safety of lenalinomide combined with rituximab in patients with relapsed/refractory diffuse large B-cell lymphomaVadim Ivanov, Diane Coso, Bruno Chetaille, et al.International Journal of Cancer|February 18, 2011
High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinomaJocelyne Jacquemier, François Bertucci, Pascal Finetti, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 10, 2010
B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their functionNacer-Eddine Serriari, Françoise Gondois-Rey, Yves Guillaume, et al.Blood|October 12, 2012
HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cellsJonathan Florentin, Besma Aouar, Clélia Dental, et al.Journal of Clinical Immunology|August 24, 2012
Increased T-cell activation and Th1 cytokine concentrations prior to the diagnosis of B-cell lymphoma in HIV infected patientsDavid Eric Ouedraogo, Alain Makinson, Nils Kuster, et al.Journal of Cell Science|March 5, 2004
Dynamic recruitment of the adaptor protein LAT: LAT exists in two distinct intracellular pools and controls its own recruitmentGrégory Bonello, Nicolas Blanchard, Maria C Montoya, et al.Cancers|April 3, 2021
Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic MelanomaFrançoise Gondois-Rey, Magali Paul, Florence Alcaraz, et al.Frontiers in Immunology|March 15, 2018
The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic CellsVaclav Janovec, Besma Aouar, Albert Font-Haro, et al.Pageof 26